Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07465289 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Name: A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis — clinical trial record (NCT07465289)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MyVisionXT

StatusRecruiting

PhasePhase 3

SponsorUCB Biopharma SRL

Started2026-09-16

View on ClinicalTrials.gov ↗

Amendment history

2026-09-25

Recruitment opened

Trial sites expanded: 0 → 7 locations

2026-08-24

Study Identification, Study Status, Eligibility v1

Start date2026-07-27→2026-09-16

2026-03-06

Original filing

UCB Biopharma SRL

68 trials monitored

See 4 trials at risk

Myasthenia Gravis

187 trials monitored

See 7 trials at risk

The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.

Trial Details

NCT Number	NCT07465289
Lead Sponsor	UCB Biopharma SRL
Conditions	Ocular Myasthenia Gravis
Enrollment	100 participants
Start Date	2026-09-16
Primary Completion	2031-01-23 (estimated)
Study Completion	2031-01-23 (estimated)
Updated on ClinicalTrials.gov	2026-09-24